Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Sex hormones, especially androgens, play a key role in causing acne.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.